Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BETA DRUGS vs VAISHALI PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BETA DRUGS VAISHALI PHARMA BETA DRUGS /
VAISHALI PHARMA
 
P/E (TTM) x - 191.5 - View Chart
P/BV x 12.8 5.8 218.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BETA DRUGS    VAISHALI PHARMA
EQUITY SHARE DATA
    BETA DRUGS
Mar-24
VAISHALI PHARMA
Mar-24
BETA DRUGS /
VAISHALI PHARMA
5-Yr Chart
Click to enlarge
High Rs1,595204 783.4%   
Low Rs645115 561.2%   
Sales per share (Unadj.) Rs307.780.5 382.3%  
Earnings per share (Unadj.) Rs37.90.7 5,653.1%  
Cash flow per share (Unadj.) Rs48.11.1 4,201.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs163.533.4 489.4%  
Shares outstanding (eoy) m9.6110.72 89.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.62.0 184.0%   
Avg P/E ratio x29.5237.4 12.4%  
P/CF ratio (eoy) x23.3139.1 16.7%  
Price / Book Value ratio x6.94.8 143.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m10,7651,707 630.7%   
No. of employees `000NANA-   
Total wages/salary Rs m20114 1,434.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,957863 342.7%  
Other income Rs m1420 70.9%   
Total revenues Rs m2,972883 336.5%   
Gross profit Rs m59917 3,591.9%  
Depreciation Rs m985 1,925.6%   
Interest Rs m2823 124.4%   
Profit before tax Rs m4889 5,265.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1232 5,950.2%   
Profit after tax Rs m3647 5,067.7%  
Gross profit margin %20.31.9 1,048.1%  
Effective tax rate %25.322.4 112.9%   
Net profit margin %12.30.8 1,478.8%  
BALANCE SHEET DATA
Current assets Rs m1,876745 251.7%   
Current liabilities Rs m944331 285.4%   
Net working cap to sales %31.548.0 65.6%  
Current ratio x2.02.3 88.2%  
Inventory Days Days1313 99.4%  
Debtors Days Days9782,091 46.8%  
Net fixed assets Rs m74853 1,422.4%   
Share capital Rs m96107 89.7%   
"Free" reserves Rs m1,475251 587.8%   
Net worth Rs m1,571358 438.7%   
Long term debt Rs m6036 167.9%   
Total assets Rs m2,624798 328.9%  
Interest coverage x18.31.4 1,298.5%   
Debt to equity ratio x00.1 38.3%  
Sales to assets ratio x1.11.1 104.2%   
Return on assets %15.03.7 399.7%  
Return on equity %23.22.0 1,155.3%  
Return on capital %31.68.1 390.1%  
Exports to sales %15.021.4 70.4%   
Imports to sales %0.42.1 16.6%   
Exports (fob) Rs m445184 241.3%   
Imports (cif) Rs m1018 57.0%   
Fx inflow Rs m445184 241.3%   
Fx outflow Rs m4120 202.2%   
Net fx Rs m404164 246.1%   
CASH FLOW
From Operations Rs m3098 3,832.7%  
From Investments Rs m-14012 -1,161.4%  
From Financial Activity Rs m-75-14 529.0%  
Net Cashflow Rs m956 1,594.1%  

Share Holding

Indian Promoters % 66.7 26.3 253.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.3 0.0 -  
FIIs % 1.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 33.3 73.7 45.2%  
Shareholders   2,567 18,983 13.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BETA DRUGS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on BETA DRUGS vs VAISHALI PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BETA DRUGS vs VAISHALI PHARMA Share Price Performance

Period BETA DRUGS VAISHALI PHARMA S&P BSE HEALTHCARE
1-Day 5.14% -1.62% 1.23%
1-Month 5.14% -10.65% -0.24%
1-Year 5.14% -87.80% 43.62%
3-Year CAGR 1.68% -21.21% 20.35%
5-Year CAGR 1.01% -8.85% 26.24%

* Compound Annual Growth Rate

Here are more details on the BETA DRUGS share price and the VAISHALI PHARMA share price.

Moving on to shareholding structures...

The promoters of BETA DRUGS hold a 66.7% stake in the company. In case of VAISHALI PHARMA the stake stands at 26.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BETA DRUGS and the shareholding pattern of VAISHALI PHARMA .

Finally, a word on dividends...

In the most recent financial year, BETA DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

VAISHALI PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BETA DRUGS , and the dividend history of VAISHALI PHARMA .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.